Literature DB >> 10560597

Postural tachycardia syndrome: clinical features and follow-up study.

P Sandroni1, T L Opfer-Gehrking, B R McPhee, P A Low.   

Abstract

OBJECTIVE: To define the clinical features and outcome of postural tachycardia syndrome (POTS).
MATERIALS AND METHODS: In this cross-sectional study of the autonomic symptom profile, inclusion criteria were orthostatic heart rate increment of 30 beats/min or greater, orthostatic symptoms, completion of a standardized autonomic test battery, and follow-up of 18 months or longer. We used 2 instruments. The first part was a structured and validated autonomic symptom profile (108 patients). The second part was a structured questionnaire focused on autonomic status on prospective follow-up (40 patients) (mean +/- SD follow-up, 67+/-52 months).
RESULTS: Most patients had frequent, persistent, and at least moderately severe symptoms for less than 5 years. The following orthostatic symptoms occurred in more than 75% of subjects: light-headedness or dizziness, lower extremity or diffuse weakness, disequilibrium, tachycardia, and shakiness. Nonorthostatic symptoms included dry eyes or mouth, gastrointestinal complaints of bloating, early satiety, nausea, pain, and alternating diarrhea and constipation. Half of the patients reported an antecedent illness presumed to be of viral origin. On follow-up, 80 % of patients were improved, 60% were functionally normal, and 90% were able to return to work. Patients who had an antecedent event appeared to do better than those with spontaneous POTS. Salt supplementation and beta-blockers were the most efficacious therapies.
CONCLUSION: In the majority of patients, POTS is self-resolving, especially in those with a triggering event.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  1999        PMID: 10560597     DOI: 10.4065/74.11.1106

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  52 in total

Review 1.  Postural tachycardia syndrome--current experience and concepts.

Authors:  Christopher J Mathias; David A Low; Valeria Iodice; Andrew P Owens; Mojca Kirbis; Rodney Grahame
Journal:  Nat Rev Neurol       Date:  2011-12-06       Impact factor: 42.937

2.  Intravenous Hydration for Management of Medication-Resistant Orthostatic Intolerance in the Adolescent and Young Adult.

Authors:  Jeffrey P Moak; Derek Leong; Robin Fabian; Vicki Freedenberg; Elizabeth Jarosz; Carol Toney; Sridhar Hanumanthaiah; Anil Darbari
Journal:  Pediatr Cardiol       Date:  2015-10-07       Impact factor: 1.655

3.  Patients With Fibromyalgia Have Significant Autonomic Symptoms But Modest Autonomic Dysfunction.

Authors:  Ann Vincent; Mary O Whipple; Phillip A Low; Michael Joyner; Tanya L Hoskin
Journal:  PM R       Date:  2015-08-24       Impact factor: 2.298

4.  Persistent splanchnic hyperemia during upright tilt in postural tachycardia syndrome.

Authors:  Julian M Stewart; Marvin S Medow; June L Glover; Leslie D Montgomery
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-02       Impact factor: 4.733

5.  Splanchnic hyperemia and hypervolemia during Valsalva maneuver in postural tachycardia syndrome.

Authors:  Julian M Stewart; Marvin S Medow; Leslie D Montgomery; June L Glover; Mark M Millonas
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-06-17       Impact factor: 4.733

6.  Visceral sensitization in postural tachycardia syndrome.

Authors:  Ramesh K Khurana
Journal:  Clin Auton Res       Date:  2014-02-09       Impact factor: 4.435

7.  Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome.

Authors:  Julian M Stewart; Indu Taneja; June Glover; Marvin S Medow
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-11-09       Impact factor: 4.733

8.  Autonomic dysfunction presenting as postural orthostatic tachycardia syndrome in patients with multiple sclerosis.

Authors:  Khalil Kanjwal; Beverly Karabin; Yousuf Kanjwal; Blair P Grubb
Journal:  Int J Med Sci       Date:  2010-03-11       Impact factor: 3.738

9.  Defects in cutaneous angiotensin-converting enzyme 2 and angiotensin-(1-7) production in postural tachycardia syndrome.

Authors:  Julian M Stewart; Anthony J Ocon; Debbie Clarke; Indu Taneja; Marvin S Medow
Journal:  Hypertension       Date:  2009-03-16       Impact factor: 10.190

10.  Regional blood volume and peripheral blood flow in postural tachycardia syndrome.

Authors:  Julian M Stewart; Leslie D Montgomery
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-04-29       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.